FDA
-
-
-
-
-
-
-
Sofwave Medical Reports Third Quarter 2025 Financial Results and Business Highlights
-
-
-
-
-
-
-
Sofwave Medical Reports First Quarter Fiscal 2025 Financial Results and Business Highlights
-
-
-
-
-
-
-
Sofwave to Participate in Stifel 2024 Healthcare Conference
-
-
-
-
-
-
-
Sofwave Medical Reports Second Quarter and First Half 2024 Financial Results and Business Highlights
-
-
-
-
-
-
-
Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer
-
-
-
-
-
-
-
Sofwave™ Gains Additional U.S. Patent Protection For the Company’s Proprietary SUPERB™ Technology
-
-
-
-
-
-
-
Sofwave Market Approvals For SUPERB™ Non-Invasive Wrinkle Reduction Technology Now Extend to Taiwan
-
329,400 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

